{"id":"W4389222230","doi":"10.1182/blood-2023-174443","title":"Mezigdomide (MEZI) Plus Dexamethasone (DEX) and Daratumumab (DARA) or Elotuzumab (ELO) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Results from the CC-92480-MM-002 Trial","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Daratumumab; Internal medicine; Lenalidomide; Multiple myeloma; Regimen; Dexamethasone; Oncology; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009852209,0.0006482006,0.001094483,0.0002572207,0.0001901564,0.0007284411,0.0004476874,0.0005445435,0.002012539],"category_scores_gemma":[0.000536828,0.000337418,0.001013699,0.0003807534,0.0003979874,0.0004784753,0.0003011143,0.001794175,0.0004052248],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006950764,"about_ca_system_score_gemma":0.0006701554,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007867051,"about_ca_topic_score_gemma":0.003431905,"domain_scores_codex":[0.9997224,0.0001247273,0.00002204517,0.00005917456,0.00002782362,0.00004384456],"domain_scores_gemma":[0.9997262,0.00004792157,0.00007446954,0.00002002841,0.00001261349,0.0001187238],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7935293,0.01263688,0.01476716,0.001004501,0.002302925,0.0002245886,0.0002638861,0.002919062,0.03473837,0.000170604,0.002732241,0.1347106],"study_design_scores_gemma":[0.5647684,0.3769015,0.04105703,0.00009521931,0.002245806,0.0006219779,0.00009795169,0.001246021,0.006016608,0.0002231647,0.006685875,0.00004046754],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9924806,0.004603631,0.0001849211,0.000307519,0.00005218585,0.0004711109,0.0008063958,0.00003629205,0.001057317],"genre_scores_gemma":[0.993826,0.00232735,0.0005756561,0.0003125752,0.00008293564,0.0003921771,0.00132669,0.000009765381,0.001146872],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002012539,"threshold_uncertainty_score":0.006732643,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03654031272279376,"score_gpt":0.2834137563408927,"score_spread":0.246873443618099,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}